Side Letter: Ardian’s $19bn, Eurazeo’s China fund, GP requests for flexiblility
Ardian has $19 billion for secondaries, but how easy will it be to deploy? Plus: Eurazeo progresses its China fund and how LPs are allowing GPs to be flexible in a crisis. Here’s today's brief, for our valued subscribers only.
